Screenshot of Reuters report
Reuters news agency said that the Brazilian Health Inspection Agency (ANVISA) said in a statement on the 23rd that it has authorized the Biomedical Center of the Butantan Institute in Sao Paulo to import 6 million doses. The new crown vaccine developed by Sinovac.
The Brazilian Health Surveillance Agency stated that the vaccine called “CoronaVac” is still in Phase III clinical trials in Brazil and has not been registered and widely used in Brazil.
Brazilian officials have previously stated that they plan to use the Chinese new crown vaccine as part of Brazil’s national immunization plan. Sao Paulo Governor Doria has revealed that the Brazilian Federal Government has agreed to purchase 46 million doses of the “CoronaVac” vaccine. However, Brazilian President Bolsonaro suddenly announced on October 21 that he would not buy China’s new crown vaccine, which caught many local governments by surprise. On October 23, Brazilian Federal Member Figari stated that the Brazilian Communist Party and other parties planned to appeal to the court against Bolsonaro’s ban on the purchase of 46 million doses of Chinese vaccines.
Brazil is currently the third country with the world’s third most confirmed cases of new coronary pneumonia. According to the latest data released by the Brazilian Ministry of Health on the evening of October 23, local time, there were 21,022 new confirmed cases of new coronary pneumonia in the country in a single day, with a total of 5,353,656 confirmed cases; 571 new deaths and a total of 156,471 deaths.